Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hypertension
MedTech
Medtronic claims long-sought FDA approval in renal denervation
Medtronic claimed the FDA's second green light in renal denervation this month, as it competes with Recor for a potential multibillion-dollar market.
Conor Hale
Nov 20, 2023 10:21am
Idorsia lays off 300 staff after previewing cost cuts in July
Oct 24, 2023 10:30am
Roche's bet pays off as Alnylam hypertension med hits in phase 2
Sep 7, 2023 8:55am
Roche signs onto Alnylam's midstage hypertension med for $310M
Jul 24, 2023 11:00am
Windtree faces Catch-22 conundrum for hypertension med
Jul 5, 2023 8:11am
Mineralys polishes $100M IPO ahead of phase 3 hypertension trial
Jan 19, 2023 9:10am